Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kaleido Biosciences Inc (KLDO)
OTHER OTC:KLDO
Kaleido Biosciences (KLDO) Stock Price & Analysis
195 Followers
KLDO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume407.00
Average Volume (3M)N/A
Market Cap
$4.26K
Enterprise Value-$16.80M
Total Cash (Recent Filing)$38.50M
Total Debt (Recent Filing)$21.69M
Price to Earnings (P/E)N/A
Beta102.16
Next Earnings
Nov 07, 2022EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,622,559
10 Day Avg. Volume3,576
30 Day Avg. VolumeN/A
Standard Deviation17.94
R-Squared0.01
Alpha2.77
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00900
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-15.27
Enterprise Value/Gross Profit-15.27
Enterprise Value/Ebitda0.20
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
50.84%
Insiders
0.00% Mutual Funds
1.20% Other Institutional Investors
47.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
KLDO FAQ
What was Kaleido Biosciences Inc’s price range in the past 12 months?
Currently, no data Available
What is Kaleido Biosciences Inc’s market cap?
Currently, no data Available
When is Kaleido Biosciences Inc’s upcoming earnings report date?
Kaleido Biosciences Inc’s upcoming earnings report date is Nov 07, 2022 which is 528 days ago.
How were Kaleido Biosciences Inc’s earnings last quarter?
Currently, no data Available
Is Kaleido Biosciences Inc overvalued?
According to Wall Street analysts Kaleido Biosciences Inc’s price is currently Overvalued.
Does Kaleido Biosciences Inc pay dividends?
Kaleido Biosciences Inc does not currently pay dividends.
What is Kaleido Biosciences Inc’s EPS estimate?
Kaleido Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kaleido Biosciences Inc have?
Kaleido Biosciences Inc has 42,622,560 shares outstanding.
What happened to Kaleido Biosciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kaleido Biosciences Inc?
Among the largest hedge funds holding Kaleido Biosciences Inc’s share is Flagship Pioneering Inc.. It holds Kaleido Biosciences Inc’s shares valued at N/A.
---
Kaleido Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Kaleido Biosciences Inc
Kaleido Biosciences, Inc. is a healthcare company, which focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA.
---
---